Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B

Table 3

Characteristics of patients with complete reversal versus incomplete reversal of proximal renal tubular dysfunction (PRTD) at one year.

	Complete reversal	Incomplete reversal	P value
Number	13	3
PRTD staging at baseline, (%)			0.10
(i) subclinical	8 (100)	0
(ii) overt	5 (62.5)	3 (100)
(years)	62 [61–67]	59 [56–60]	0.14
Duration of nucleotide (months)	67 [47–91]	90 [77.5–95.5]	0.44
Diabetes, (%)	1 (7.7)	0	0.81
Hypertension, (%)	2 (15.4)	1 (33.3)	0.49

expressed as median [interquartile range].